secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2024-11-21T23:59:59+00:00
Accession:  0001193125-24-263477
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Verrica prices $42M public offering of common stock and warrants at $0.89/unit
------------------------------------------------------------------------------

- Raised ~$42M gross from 44.96M common shares, 2.24M pre-funded warrants, and 47.2M Series A/B warrants at $0.89/unit.
- Series A warrants exercisable at $1.068/sh, expire 1 year; Series B at $1.335/sh, expire 5 years.
- Offering expected to close Nov 22, 2024; Jefferies sole bookrunner with 30-day option for up to 7.08M additional shares.
- Pre-funded warrants have $0.0001 exercise price and 9.99% beneficial ownership limitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312524263477/0001193125-24-263477-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312524263477/d769920d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-263477

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer